This report on non-invasive prenatal testing (NIPT) market gives an all-inclusive view of the NIPT industry based on products, regional categories. The study offers market size and forecast (USD Mn) of its segments for the period 2014-2023, with respective CAGRs (value %) for the period 2016-2023, while considering 2015 as the base year. Market dynamics such as drivers, challenges and future prospects, and major commercial events are discussed in this report for evaluation of the overall market trends.

Over the decade, the global non-invasive prenatal testing (NIPT) has shown a healthy growth. The rise in the global average of maternal age, coupled with the increasing incidence of Down syndrome in newborns, has boosted the market to a significant level. Additionally, the augmenting demand for timely and non-invasive fetal diagnosis is anticipated to propel the market in the coming years.

Over the past few years, the global non-invasive prenatal testing market has underwent phenomenal growth with several tests being introduced commercially. Rise in maternal age, and growing incidence of genetic abnormalities in newborns are the most significant drivers of this market. This report scrutinizes the major NIPT tests currently available in the market, namely, MaterniT21 PLUS, BambniTest, informaSeq Prenatal Test, Harmony Prenatal Test, Non-invasive Fetal Trisomy (NIFTY) Test. verifi, PrenaTest, Panorama Test, VisibiliT Test and others.

The market size and forecast for the period 2014-2023 along with the CAGRs for the period 2016-2023 for the mentioned segments are also presented in this study.

Along with the quantitative information sets, this report also includes market assessment tools such as attractive investment proposition, major commercial events, and fractal map analysis for competitive assessment of the global non-invasive prenatal testing market. This report concludes with company profiles section that highlights key information about the major market players engaged in development, manufacture, distribution and sale of non-invasive prenatal tests in the international markets.

MaterniT21 PLUS, BambniTest, informaSeq Prenatal Test, Harmony Prenatal Test, Non-invasive Fetal Trisomy (NIFTY) Test, verifi, PrenaTest, Panorama Test, VisibiliT Test and others are the major NIPT test types studied for the purpose of this research. Among these test types, the MaterniT21 PLUS test holds the largest market share in 2015. The test exhibits the capability of diagnosing a wide range of chromosomal abnormalities such as Trisomy 13, Trisomy, 18, Trisomy 21, Trisomy 16, microdeletions such as DiGeorge syndrome, Jacobsen syndrome, 1q36 deletion syndrome, Langer-Gidion syndrome, Wolf-Hirschhorn syndrome. The test first received approval in 2011 for diagnosis of Trisomy 21. Growth in the average maternity age, rise in disposable income, and offered convenience in terms of early disease detection are the prime factors that drive the growth of this market. On the other hand, stringent government guidelines, and the ethical dilemma associated with prenatal testing may hold back the growth of this market. 

At present, North America is the leading regional market for NIPT tests, with over 50% market revenue in 2015. United States being one of the wealthiest countries in the world, is characterized by high awareness about the repercussions of genetic abnormalities, high disposable income, as well as well-structured reimbursement policies. Additionally, Asia-Pacific is the fastest growing regional market for NIPT tests. Countries such as South Korea, Japan, China and India greatly determine the market trends in this region. In Japan, approximately 60% women have higher than 1:1,000 risk of having a child with Down’s syndrome. Moreover, the number of mothers above the age of 30 is also high in the country. Among these women, a significant section opt fall under the high risk group of maternity age of 35 and above. These women represent the potential customers for NIPT testing. As per the guidelines set by the Japan Society of Gynecology, NIPT tests would be made available to pregnant women in the mentioned age-group and such women who are found at risk of carrying a genetically abnormal fetus during earlier tests.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Non-Invasive Prenatal Testing market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Non-Invasive Prenatal Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Non-Invasive Prenatal Testing market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Non-Invasive Prenatal Testing market?
• Which is the largest regional market for Non-Invasive Prenatal Testing market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Non-Invasive Prenatal Testing market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Non-Invasive Prenatal Testing market worldwide?